A mobile app–based program for facilitating advance care planning discussions between patients with advanced cancer and oncologists: A randomized controlled trial (J-SUPPORT 2104). This is an ASCO ...
MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes remained nearly identical when patients used its MiniMed 780G automated insulin ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する